Tokyo Tape
Sign in
← Fukuda Denshi

Quarterly report · Q3

6960.TEDINET S100ST0Z
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥99.3bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥134.6bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥93.5bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥19.3bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥16.1bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥19.6bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥25.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥16.8bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥19.8bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥16.9bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥13.6bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥17.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥11.6bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥13.6bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥11.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥210.7bnat 2023-12-31Cons.Assets
Total assets¥206.9bnat 2023-03-31Cons.Assets
Total assets¥195.2bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥37.5bnat 2023-12-31Cons.Liabilities
Total liabilities¥43.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥173.2bnat 2023-12-31Cons.Net assets
Net assets / equity¥163.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥156.6bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥65.9bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥68.0bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥450.772023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥126.462023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥571.252022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥383.712022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥115.282022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio82.2%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio78.8%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio80.2%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue2023-04-01 → 2023-12-31¥29.7bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue external2023-04-01 → 2023-12-31¥29.7bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentsegment profit2023-04-01 → 2023-12-31¥5.4bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2023-04-01 → 2023-12-31¥44.1bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2023-04-01 → 2023-12-31¥44.1bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2023-04-01 → 2023-12-31¥9.4bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2023-04-01 → 2023-12-31¥6.0bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2023-04-01 → 2023-12-31¥6.0bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2023-04-01 → 2023-12-31¥1.1bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2023-04-01 → 2023-12-31¥19.5bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2023-04-01 → 2023-12-31¥19.5bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2023-04-01 → 2023-12-31¥3.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥99.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥99.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥19.3bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥25.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥25.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.9bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥40.5bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥40.5bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥8.9bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥7.5bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥7.5bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.2bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥20.0bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥20.0bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥3.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥93.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥93.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥16.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 365
ItemContextValueUnit
Income taxesPrior1YTDDuration5271000000JPY
Income taxesCurrentYTDDuration6122000000JPY
Profit lossPrior1YTDDuration11606000000JPY
Profit lossCurrentYTDDuration13636000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration11606000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration13636000000JPY
Profit lossPrior1YTDDuration11606000000JPY
Profit lossCurrentYTDDuration13636000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration103000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration1861000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration209000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration197000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration31000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-29000000JPY
Other comprehensive incomePrior1YTDDuration344000000JPY
Other comprehensive incomeCurrentYTDDuration2029000000JPY
Comprehensive incomePrior1YTDDuration11950000000JPY
Comprehensive incomeCurrentYTDDuration15666000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration11950000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration15666000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E02304-000PhysiologicalDiagnosticEquipmentReportableSegmentsMember19973000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E02304-000PatientMonitoringEquipmentReportableSegmentsMember7490000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E02304-000MedicalTreatmentEquipmentReportableSegmentsMember40534000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E02304-000ConsumablesAndOtherProductsReportableSegmentsMember25483000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember93481000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration93481000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E02304-000PhysiologicalDiagnosticEquipmentReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E02304-000PatientMonitoringEquipmentReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E02304-000MedicalTreatmentEquipmentReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E02304-000ConsumablesAndOtherProductsReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E02304-000PhysiologicalDiagnosticEquipmentReportableSegmentsMember19973000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E02304-000PatientMonitoringEquipmentReportableSegmentsMember7490000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E02304-000MedicalTreatmentEquipmentReportableSegmentsMember40534000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E02304-000ConsumablesAndOtherProductsReportableSegmentsMember25483000000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember93481000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember－JPY
Net salesPrior1YTDDuration93481000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E02304-000PhysiologicalDiagnosticEquipmentReportableSegmentsMember3000000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E02304-000PatientMonitoringEquipmentReportableSegmentsMember1245000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E02304-000MedicalTreatmentEquipmentReportableSegmentsMember8929000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E02304-000ConsumablesAndOtherProductsReportableSegmentsMember2902000000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember16077000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember－JPY
Operating incomePrior1YTDDuration16077000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q3r_E02304-000PhysiologicalDiagnosticEquipmentReportableSegmentsMember19515000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q3r_E02304-000PatientMonitoringEquipmentReportableSegmentsMember5989000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass